In vivo radioprotection by 5-aminosalicylic acid

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 650, Issue 1, 2008, Pages 63-79

  Mantena, S K ^a   Unnikrishnan, M K ^a   Joshi, Ravi ^b   Radha, V ^c   Devi, P Uma ^d   Mukherjee, T ^b  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

^c CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^d Jawaharlal Nehru Cancer Hospital & Research Centre Bhopal   (India)

Author keywords

5 Aminosalicylic acid (5ASA); DNA damage; Gamma radiation; p53 p21; Survival

Indexed keywords

MESALAZINE; PLASMID DNA; PROTEIN P21; PROTEIN P53;

ARTICLE; BONE MARROW; CHROMOSOME ABERRATION; DRUG EFFICACY; FENTON REACTION; GAMMA RADIATION; IN VIVO STUDY; IRRADIATION; METAPHASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE RADIOLYSIS; RADIATION PROTECTION; SPLEEN; STATISTICAL SIGNIFICANCE; SURVIVAL;

ANIMALS; BONE MARROW; CELL-FREE SYSTEM; CHROMOSOME ABERRATIONS; GAMMA RAYS; KINETICS; LIPID PEROXIDATION; MALE; MESALAMINE; MICE; RADIATION-PROTECTIVE AGENTS; SPLEEN; TUMOR SUPPRESSOR PROTEIN P53; WHOLE-BODY IRRADIATION;

MUS;

EID: 38049098582     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2007.10.005     Document Type: Article

References (83)

1. Barcellos-Hoff M.H., Park C., and Wright E.G. Radiation and the microenvironment-tumorigenesis and therapy. Nat. Rev.-Cancer 58 (2005) 867-875
2. Sonntag V.C. The Chemical Basis of Radiation Biology (1987), Taylor and Francis, London
3. Weiss J.F., and Kumar K.S. Antioxidant mechanisms in radiation injury and radioprotection. In: Chow C.K. (Ed). Cellular Antioxidant Defence Mechanisms (1988), CRC Press, Florida 163-189
4. Monig H., Messerschmidt O., and Streffer C. In: Scherer E., Streffer C., and Trott K.R. (Eds). Chemical radioprotection in mammals and in man. Radiation exposure and occupational risks (1990), Springer-Verlag, Berlin 97-143
5. Uma Devi P. Normal tissue protection in cancer therapy: progress and prospects. Acta Oncol. 37 (1998) 247-252
6. Tannehill S.P., and Mehta M.P. Amifostine and radiation therapy: past, present, and future. Semin. Oncol. 23 (1996) 69-77
7. DiMasi J.A. New drug development in the United States from 1963 to 1999. Clin. Pharmacol. Ther. 69 (2001) 286-296
8. Rhodes J., Thomas G., and Evans B.K. Inflammatory bowel disease management. Some thoughts on future drug developments. Drugs 3 (1997) 189-194
9. Peskar B.M., Dreyling K.W., May B., Schaarschmidt K., and Goebell H. Possible mode of action of 5-aminosalicylic acid. Dis. Dig. Sci. 32 (1987) S51-S56
10. Miles A.M., and Grisham M.B. Antioxidant properties of aminosalicylates. Methods Enzymol. 234 (1994) 555-572
11. Conner E.M., Brand S.J., Davis J.M., Kang D.Y., and Grisham M.B. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. Inflamm. Bowel Dis. 2 (1996) 133-147
12. Keshavarzian A., Sedghi S., Kanofsky J., List T., Robinson C., Ibrahim C., and Winship D. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 103 (1992) 177-185
13. Lih-Brody L., Powell S.R., Collier K.P., Reddy G.M., Cerchia R., Kahn E., Weissman G., Katz S., Floyd R.A., McKinley M.J., Fisher S.E., and Mullin G.E. Increased oxidative stress and decreased antioxidant defenses of inflammatory bowel disease. Dig. Dis. Sci. 41 (1996) 2078-2086
14. Millar A.D., Rampton D.S., Chander C.L., Claxson A.W.D., Blades S., Coumbe A., Panetta J., Morris C.J., and Blake D.R. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39 (1996) 407-415
15. Goncalves E., Almeida L.M., and Dinis T.C.P. Antioxidant activity of 5-aminosalicylic acid against peroxidation of phosphatidylcholine liposomes in the presence of α-tocopherol. A synergistic interaction?. Free Radical Res. 29 (1998) 53-66
16. Fischer-Nielsen A., Poulsen H.E., and Loft S. 8-Hydroxydeoxyguanosine in vitro: effects of glutathione, ascorbate and 5-aminosalicylic acid. Free Radical Biol. Med. 13 (1992) 121-126
17. Fischer-Nielsen A., Jeding I.B., and Loft S. Radiation-induced formation of 8-hydroxy-2′-deoxyguanosine and its prevention by scavengers. Carcinogenesis 15 (1994) 1609-1612
18. Fischer-Nielsen A., Loft S., and Jensen K.G. Effect of ascorbate and 5-aminosalicylic acid on light-induced 8-hydroxydeoxyguanosine formation in V79 hamster cells. Carcinogenesis 14 (1993) 2431-2433
19. Baugham C.A., Canney P.A., Buchanan R.B., and Pickering R.M. A randomized trail to assess the efficiency of 5-aminosalicylic acid for prevention of radiation enteritis. Clin. Oncol. (R. Coll. Radiol.) 5 (1993) 19-24
20. Freund U., Scholmerich J., Siems H., Kluge F., Schafer H.E., and Wannenmachner M. Unerwunschte Nebenwirkungen bie Anwendung von Mesalzine (5-aminosalicylic acid) under Strahlentherapie. Strahlenther. Onkol. 163 (1987) 678-680
21. Kilic D., Ozenirler S., Egenhan I., and Dursun A. Sulfasalazine decreases acute gastrointestinal complications due to pelvic radiotherapy. Ann. Pharmacother. 35 (2001) 806-810
22. Kilic D., Ozenirler S., Egenhan I., and Dursun A. Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy. Radiother. Oncol. 57 (2000) 125-129
23. Sudheer Kumar M., Unnikrishnan M.K., and Uma Devi P. Effect of 5-aminosalicylic acid on radiation-induced micronuclei in mouse bone marrow. Mutat. Res. 527 (2003) 7-14
24. Jagetia G.C., and Ganapathi N.G. Effect of copperglycinate on the radiation induced micronuclei formation in mice bone marrow. Radiat. Environ. Biophys. 29 (1990) 115-118
25. C.N. Coleman, W.F. Blakely, J.R. Fike, T.J. Mac Vitte, N.F. Metting, J.B. Mitchell, J.E. Moulder, R.J. Preston, T.M. Seed, H.B. Stone, P.J. Tofilon, R.S.L. Wong, Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland, December 17-18, 2001, Radiat. Res. 159 (2003) 812-834.
26. Uma Devi P., Ganasoundari A., Rao B.S.S., and Srinivasan K.K. In vivo radioprotection by Ocimum flavonoids: survival of mice. Radiat. Res. 151 (1999) 74-78
27. Ganasoundari A., Devi P.U., and Rao B.S. Enhancement of bone marrow radioprotection and reduction of WR-2721 toxicity by Ocimum sanctum. Mutat. Res. 397 (1998) 303-312
28. Uma Devi P., Bisht K.S., and Vinitha M. A comparative study of radioprotection by Ocimum flavonoids and synthetic protectors in the mouse. Br. J. Radiol. 71 (1998) 782-784
29. Savage J.R.K. Classification and relationships of induced chromosomal structural changes. J. Med. Genet. 12 (1976) 103-122
30. Bender M.A., Awa A.A., Brooks A.L., Evans H.J., Groer P.G., Littlefield L.G., Pereira C., Preston R.J., and Wachholz B.W. Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutat. Res. 196 (1988) 103-159
31. Puro E.A., and Clark G.M. The effect of exposure rate on animal lethality and spleen colony survival. Radiat. Res. 52 (1972) 115-129
32. Uma Devi P., and Prasanna P.G.S. Comparative radioprotection of mouse haemopoetic study by some thiols and a polysaccharide. Proc. Natl. Acad. Sci. Lett. 65 (1995) 1
33. Prasanna P.G., and Uma Devi P. Modification of WR-2721 radiation protection from gastrointestinal injury and death in mice by 2-mercaptopropionylglycine. Radiat. Res. 133 (1993) 111-115
34. Prabhakar K.R., Veerapur V.P., Vipan Parihar K., Priyadarsini K.I., Rao B.S.S., and Unnikrishnan M.K. Evaluation and optimization of radioprotective activity of Coronopus didymus Linn. in-irradiated mice. Int. J. Radiat. Biol. 82 (2006) 525-536
35. Midgley C.A., Owens B B., Briscoe C.V., Thomas D.B., Lane D.P., and Hall P.A. Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J. Cell Sci. 108 (1995) 1843-1848
36. Mantena S.K., and Katiyar S.K. Grape seed proanthocyanidins inhibit UV-radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling in human epidermal keratinocytes. Free Radical Biol. Med. 40 (2006) 1603-1614
37. Wijewickreme A.N., Krejpcio Z., and Kitts D.D. Hydroxyl scavenging activity of glucose, fructose and ribose-lysine model Maillard products. J. Food Sci. 64 (1999) 457-461
38. Guha S.N., Moorthy P.N., Kishore K., Naik D.B., and Rao K.N. One-electron reduction of thionine studied by pulse radiolysis. Proc. Indian Acad. Sci. (Chem. Sci.) 99 (1987) 261-271
39. Priyadarsini K.I., Naik D.B., Moorthy P.N., and Mittal J.P. Energy transfer studies of coumarin dyes using electron pulse radiolysis. In: Dobo J., Nykis L., and Shiller R. (Eds). Proceedings of the 7th Tihany Conference on Radiation Chemistry. Budapest, Hungary (1991) 105-107
40. Fielden E.M. Chemical dosimetry of pulsed electron and X-ray source in the MeV region. In: Baxendale J.H., and Busi R.D. (Eds). The Study of Fast Processes and Transient Species by Electron Pulse Radiolysis (1982), Reidel Publishing Co, London 59
41. Jagetia G.C., and Baliga M.S. Modulation of antineoplastic activity of cyclophosphamide by Alstonia scholaris in the Ehrlich ascites carcinoma-bearing mice. J. Exp. Ther. Oncol. 3 (2003) 272-282
42. Jagetia G.C., and Reddy T.K. Modulation of radiation-induced alteration in the antioxidant status of mice by naringin. Life Sci. 77 (2005) 780-794
43. Weiss J.F., and Landauer M.R. Radioprotection by antioxidants. Ann. N. Y. Acad. Sci. 899 (2000) 44-60
44. Maisin J.R., Topalova S., Kondi-Tamba A., and Matellin G. Radioprotection by polysaccharides. Pharmacol. Ther. 39 (1988) 255-259
45. Neta R. Role of cytokines in radioprotection. Pharmacol. Ther. 39 (1988) 261-266
46. Kurland J.I., Broxmeyer H.E., Pelus L.M., Bockman R.S., and Moore M.A. Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation. Blood 52 (1978) 388-407
47. Gentile P., Byer D., and Pelus L.M. In vivo modulation of murine myelopoiesis following intravenous administration of prostaglandin E2. Blood 62 (1983) 1100-1107
48. Quastler H. The nature of intestinal radiation death. Radiat. Res. 4 (1956) 303
49. Saharan B.R., Saini M.R., and Uma Devi P. MPG protection against radiation sickness and weight loss and its correlation with mortality of mice after whole body gamma irradiation. Strahlentherapie 157 (1981) 138-140
50. MacVittie T.J., Monroy R.L., Patchen M.L., and Souza L.M. Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sub-lethal and lethal whole body irradiation. Int. J. Radiat. Biol. 57 (1990) 723-736
51. Uma Devi P., Nagarathnam A., and Rao B.S.S. Cellular Radiobiology. Introduction to Radiation Biology (2000), Churchill Livingstone, New Delhi pp. 79-95
52. Carr K.E. Effects of radiation damage on intestinal morphology. Int. Rev. Cytol. 208 (2001) 1-119
53. Navarro J., Obrador E., Pellicer J.A., Aseni M., Vina J., and Estrela M. Blood glutathione as an index of radiation-induced oxidative stress in mice and humans. Free Radical Biol. Med. 22 (1997) 1203-1207
54. Jones D.P. The role of oxygen concentration in oxidative stress: hypoxic and hyperoxic models. In: Sies H. (Ed). Oxidative Stress (1985), Academic Press, New York 152-196
55. Meister A., Anderson M., and Glutathione M. Ann. Rev. Biochem. 52 (1983) 711-760
56. Modig H.G., and Revesz L. Non-protein sulphydryl and glutathione content of Ehrlich ascites tumour cells after treatment with the radioprotectors AET, cysteamine and glutathione. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 13 (1967) 469-477
57. Beno I., Staruchova M., Volkovova K., Mekinova D., Bobek P., and Jurcovicova M. Activity of the antioxidant system in patients with idiopathic proctocolitis and the effect of 5-aminosalicylic acid (Salofalk). Bratisl Lek Listy 95 (1994) 99-102
58. Valentine J.F. Mesalamine induces manganese superoxide dismutase in rat intestinal epithelial cell lines and in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001) G1044-G1050
59. Epperly M.W., Bray J.A., Esocobar P., Bigbee W.L., Watkins S., and Greenberger J.S. Overexpression of the human manganese superoxide dismutase (MnSOD) transgene in subclones of murine hematopoietic progenitor cell line 32D cl 3 decreases irradiation-induced apoptosis but does not alter G2/M or G1/S phase cell cycle arrest. Radiat. Oncol. Invest. 7 (1999) 331-342
60. Hirose K., Longo D.L., Oppenheim J.J., and Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J. 7 (1993) 361-368
61. Sun Y. Free radical antioxidant enzymes and carcinogenesis. Free Radical Biol. Med. 8 (1990) 583-599
62. Girotti A.W. Photodynamic lipid peroxidation in biological systems. Photochem. Photobiol. 51 (1990) 497-509
63. Bus J.S., and Gibson J.E. Lipid peroxidation and its role in toxicology. Rev. Biochem. Toxicol. 1 (1979) 125-149
64. Mukhtar H., and Elmets C.A. Photocarcinogenesis: mechanisms, models and human health implications. Photochem. Photobiol. 63 (1996) 355-447
65. Pearson D.C., Jourd'Heuil D., and Meddings J.B. The anti-oxidant properties of 5-aminosalicylic acid. Free Radical Biol. Med. 21 (1996) 367-373
66. Buxton G.V., Greenstock C.L., Helman W.P., and Ross A.B. Critical review of rate constants of hydrated electrons, hydrogen atoms and hydroxyl radicals ({radical dot}OH) in aqueous solution. J. Phys. Chem. 17 (1988) 513-886
67. O'Neill P., and Fielden E.M. Primary Free Radical Processes in DNA. Advances in Radiation Biology (1993), Academic Press pp. 53-120
68. Maisin J.R., Albert C., and Henry A. Reduction of short-term radiation lethality by biological response modifiers given alone or in association with other chemical protectors. Radiat. Res. 135 (1993) 332-337
69. Michalowski A.D. On radiation damage to normal tissue and treatment. Acta Oncol. 33 (1994) 139-157
70. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
71. Torres M., Al-Buhairi M., and Alsbeih G. Induction of p53 and p21 proteins by gamma radiation in skin fibroblasts derived from breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 58 (2004) 479-484
72. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1973) 817-825
73. Hanninen K., Kaukonen A.M., Kankkunen T., and Hirvonen J. Rate and extent of ion-exchange process: the effect of physico-chemical characteristics of salicylate anions. J. Control Release 91 (2003) 449-463
74. Turrisi A.T., Kligerman M.M., Glover D.J., Glick J.H., Norfleet L., and Gramouski M M. Experience with Phase I trials of WR-2721 preceding radiation therapy. In: Nygaard O.F., and Simic M.G. (Eds). Radioprotectors and Anticarcinogens (1983), Academic Press, New York 681-694
75. B. Vrinda. Pre-clinical Studies on the Radio- and Chemoprotective Potential of Ocimum Flavonoids, Orientin and Vicenin, PhD thesis, Manipal Academy of Higher Education, Manipal, India, 2002.
76. Yuhas J.M., Davis M.E., Glover D., Brown D.Q., and Ritter M. Circumvention of the tumor membrane barrier to WR-2721 absorption by reduction of drug hydrophilicity. Int. J. Radiat. Oncol. Biol. Phys. 8 (1982) 519-522
77. Yuhas J.M. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 40 (1980) 1519-1524
78. Pinczowski D., Ekbom A., Baron J., Yuen J., and Adami H.O. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 107 (1994) 117-120
79. Brown W.A., Farmer K.C., Skinner S.A., Malcontenti-Wilson C., Misajon A., and O'Brien P.E. 5-aminosalicyclic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer. Dig. Dis. Sci. 45 (2000) 1578-1584
80. Andrianopoulos G.D., Nelson R.L., Barch D.H., and Nyhus L.M. Sulfasalazine alters the character of dimethylhydrazine-induced colorectal carcinoma in rats. Anticancer Res. 9 (1989) 1725-1728
81. Davis A.E., Patterson F., and Crouch R. The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model. Br. J. Cancer 66 (1992) 777-780
82. Rodenburg R.J., Ganga A., van Lent P.L., van de Putte L.B., and van Venrooij W.J. The anti-inflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosis. Arthritis Rheum. 43 (2000) 1941-1950
83. Munkholm P., Loftus E.V., Reinacher-Schick A., Kornbluth A., Mittmann U., and Esendal B. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates. Digestion 73 (2006) 11-19